Category: Biopharmaceuticals
North America Biopharmaceuticals
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035
... / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035 BIOLOGICS CONTRACT MANUFACTURING ... Read More
-
2024 North America Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global biologics contract manufacturing market is set for remarkable growth, with worldwide revenue anticipated to increase from USD 16.01 billion in 2024 to an impressive USD 36.3 billion by 2031. Projected to grow at ... Read More
-
2024 North America Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 United States Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
North America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The North America bioprocessing market was valued at US$ 12,440.60 million in 2023 and is expected ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Pegfilgrastim is a long-acting form of filgrastim that stimulates the bone marrow to produce more white blood cells. Pegfilgrastim biosimilars are ... Read More
-
North America Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
... and Multi-use), and Mode (In-house and Outsourced) The North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to ... Read More
-
US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2024-2028)
... spanning from 2024 to 2028. Growth in the US biosimilar market is supported by factors such as rising prevalence of cancer, growing geriatric population and favorable environment. However, the market growth is expected to be ... Read More
-
Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global biosimilars market growth is driven by rising healthcare costs worldwide and the expiration of blockbuster ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Downstream processing refers to the purification and recovery steps in bioprocessing undertaken ... Read More
-
2024 North America Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 United States Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2024-2032
... 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing cellular therapies and biomarker testing, escalating need to reduce ... Read More
Research Assistance
